Simplification to Stribild vs continuation of RTV-boosted DRV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-PI subgroup analysis

INTRODUCTION: Simplification to Stribild (STB) was statistically superior to continuation of a ritonavir-boosted protease inhibitor (PI+RTV) with emtricitabine and tenofovir DF (FTC/TDF) at week (W) 48 in virologically suppressed HIV adults (1). We report the W48 efficacy and safety of STB versus RT...

Descripción completa

Detalles Bibliográficos
Autores principales: Arribas, Jose, Rizzardini, Giuliano, Arasteh, Keikawus, Zurawski, Christine, Dietz, Craig, Pontani, Dennis, Garner, Will, Nguyen, Thai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P273
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225406/
https://www.ncbi.nlm.nih.gov/pubmed/25397549
http://dx.doi.org/10.7448/IAS.17.4.19805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225406/
https://www.ncbi.nlm.nih.gov/pubmed/25397549
http://dx.doi.org/10.7448/IAS.17.4.19805

Ejemplares similares